Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone-Reference-Cited by-同舟云学术

Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone

Published:2008-10 Issue:4 Volume:7 Page:286-289
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Rossi Peter J.,Urbanic James,Clark Peter E.,McCullough David L.,Lee W. Robert

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference17 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

2. The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management;Cooperberg;J Clin Oncol,2004

3. The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S;Mettlin;Cancer,1999

4. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;JAMA,1998

5. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy;D'Amico;N Engl J Med,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of early PSA failure time with increased distant metastasis and decreased survival in prostate brachytherapy patients;Radiotherapy and Oncology;2014-02

2. Patient Selection and Recommendations on Permanent Seed Implantation as Monotherapy for Localized Prostate Cancer;Interstitial Prostate Brachytherapy;2013

3. Prostate-Specific Antigen Velocity Before and After Elimination of Factors That Can Confound the Prostate-Specific Antigen Level;International Journal of Radiation Oncology*Biology*Physics;2012-03

4. Future of Treatment for Low-Risk Prostate Cancer: For All, for Some, or for None?;Journal of Clinical Oncology;2011-05-20